indicated for mod-severe persistent, allergic asthma in pts +12 with pos skin test to perennial aeroallergen and inadequately controlled symptoms on inhaled steroids (step 5 or 6 per guidelines)
Nucala
Mepolizumab (IL-5 receptor antagonist)
add-on maintenance treatment of severe asthma in adults with an eosinophilic phenotype
can cause shingles
Cinqair
Reslizumab (IL-5 receptor antagonist)
add-on maintenance treatment of severe asthma in adults with an eosinophilic phenotype